Clinical Trial Update: Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer [NA]

View source ↗

Summary

A completed clinical trial assessing whether dexamethasone plus either ondansetron or palonosetron reduces nausea and vomiting in patients with early-stage brea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Ondansetron (ondansetron)
• Palonosetron (palonosetron)

Snippet

Sponsor: University of Washington | Conditions: Male Breast Cancer, Nausea and Vomiting | NA | Status: COMPLETED | Results posted: 2017-07-11